125 results on '"Oberstein, Paul E."'
Search Results
2. Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma.
3. Figure S2 from Elevated Dietary Carbohydrate and Glycemic Intake Associate with an Altered Oral Microbial Ecosystem in Two Large U.S. Cohorts
4. Table S3 from Elevated Dietary Carbohydrate and Glycemic Intake Associate with an Altered Oral Microbial Ecosystem in Two Large U.S. Cohorts
5. Data from Elevated Dietary Carbohydrate and Glycemic Intake Associate with an Altered Oral Microbial Ecosystem in Two Large U.S. Cohorts
6. Data from Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness
7. Supplementary Data from Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness
8. Figure S3 from Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment Response
9. Supplementary Data from Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment Response
10. Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies
11. Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies
12. Elevated Dietary Carbohydrate and Glycemic Intake Associate with an Altered Oral Microbial Ecosystem in Two Large U.S. Cohorts
13. Reply to ‘H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines’
14. Abstract PR010: Single-cell sequencing elucidates the effects of chemotherapy on cancer cell heterogeneity and the tumor microenvironment of human pancreatic adenocarcinoma
15. Abstract PR005: Primary results of PanCAN-SR1, a phase 1b study evaluating Gemcitabine, nab-Paclitaxel, Canakinumab, and Spartalizumab to target IL-1β and PD-1 in metastatic pancreatic cancer with correlative tissue and blood biomarker analysis
16. Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting
17. Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies.
18. Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancer
19. Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting.
20. Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies.
21. Use of adjuvant radiation therapy in the management of acinar cell carcinoma of the pancreas: results from the Survival, Epidemiology, and End Results database
22. Cancer surveillance awareness and practice among families at increased risk for pancreatic adenocarcinoma
23. Su1408 YIELD AND IMPACT OF SOMATIC MUTATIONAL ANALYSIS IN EUSGUIDED BIOPSY OF PANCREATIC ADENOCARCINOMA
24. The functional and phenotypic diversity of single T-cell infiltrates in human colorectal cancer as correlated with clinical outcome
25. Metastatic Gastric Large Cell Neuroendocrine Carcinoma: A Case Report and Review of Literature
26. Abstract LB-003: OncoMatch: Unbiased, quantitative assessment of cancer model fidelity for drug sensitivity and mechanism of action elucidation
27. The Achilles’ Heel of Pancreatic Cancer: Targeting pancreatic cancer's unique immunologic characteristics and metabolic dependencies in clinical trials
28. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
29. Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment Response
30. Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME) in vivo
31. Unbiased Assessment of H-STS cells as high-fidelity models for gastro-enteropancreatic neuroendocrine tumor drug mechanism of action analysis
32. Cholinergic Signaling Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness
33. Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
34. Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness
35. Parasympathetic signaling via Chrm1 directly suppresses pancreatic carcinogenesis and cancer stemness through inhibition of EGFR/MAPK and PI3K/AKT pathway
36. Transcriptional deconvolution reveals consistent functional subtypes of pancreatic cancer epithelium and stroma
37. HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma
38. Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
39. Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer
40. Pancreatic Neuroendocrine Tumors: Entering a New Era
41. Novel Agents in the Treatment of Unresectable Neuroendocrine Tumors
42. First-Line Treatment for Advanced Pancreatic Cancer
43. Abstract PR01: Paradoxical acceleration of pancreatic tumorigenesis through Smoothened inhibition: A post-clinical trial in genetically engineered mice
44. Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
45. Uptake and Patterns of Use of Gemcitabine for Metastatic Pancreatic Cancer: A Population-Based Study
46. Abstract 1637: Depletion of tumor stroma with Smoothened inhibition leads to altered epithelial differentiation and paradoxical acceleration of pancreatic tumorigenesis.
47. Pancreatic cancer: why is it so hard to treat?
48. Safety and Efficacy of Everolimus in Adult Patients with Neuroendocrine Tumors
49. Pancreatic Neuroendocrine Tumors: Entering a New Era.
50. Novel Agents in the Treatment of Unresectable Neuroendocrine Tumors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.